Name: UMIN ID:
Unique ID issued by UMIN | UMIN000042218 |
---|---|
Receipt number | R000048189 |
Scientific Title | The efficacy and safety of taxane therapy after discontinuation of nivolumab therapy in Japanese patients with advanced or recurrent esophageal cancer:a retrospective observational study (AFTER NIVO ESO Study) |
Date of disclosure of the study information | 2020/10/23 |
Last modified on | 2023/01/12 17:24:46 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2020/10/23 10:24:52 | ||
2 | Update | 2021/03/10 16:39:08 | Address Address TEL |
|
3 | Update | 2021/03/10 16:42:41 | Recruitment status |
|
4 | Update | 2021/07/13 16:18:53 | Last name of contact person Last name of contact person |
|
5 | Update | 2021/10/25 11:06:50 | Recruitment status |
|
6 | Update | 2022/08/23 15:30:04 | Date of closure to data entry Date trial data considered complete |
|
7 | Update | 2022/08/23 15:30:58 | Date of closure to data entry Date trial data considered complete |
|
8 | Update | 2023/01/12 17:20:57 | Recruitment status |
|
9 | Update | 2023/01/12 17:24:46 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |